Home Newsfeeds Advent, Stada Among Suitors For Viatris OTC ARM

Advent, Stada Among Suitors For Viatris OTC ARM

-Bloomberg

byBenzinga Newsdesk

February 9, 2023

1 minute read

-Bloomberg

News

Oncorus Announces Publication In Nature Communications Highlighting The Development Of Its Intravenously Administered Synthetic vRNA/LNP Platform For The Treatment Of Cancer

By Benzinga Newsdesk

October 7, 9:06 AM

ANDOVER, Mass., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (NASDAQ:ONCR), a viral immunotherapies company focused on stimulating the immune system to transform outcomes for cancer patients, today announced the

ONCR

Albertsons Companies Issues Statement Regarding The Further Delay Of The Washington State Court’s Hearing On Its Special Dividend Payment

By Benzinga Newsdesk

November 16, 2:03 PM

Albertsons Companies (NYSE:ACI) ("Albertsons Cos." or "the Company") today announced that the Washington State Court has postponed the date of the hearing regarding the temporary restraining order

ACI

Amarin Corporation Shareholders Have Voted To Elect All 7 Of Sarissa’s Nominees, Remove Per Wold-Olsen As Chairman Of Board Effective Immediately

By Happy Mohamed

February 28, 11:40 AM

Amarin Corporation plc (NASDAQ:AMRN) ("Amarin" or the "Company") today announced that, based on the preliminary voting results provided by its proxy solicitors following the Company's 2023 General Meeting of Shareholders (the "General Meeting"), Amarin shareholders have voted to elect all sev

AMRN

Alibaba Slumps 4% After Reports Of Jack Ma’s Plan For Ant: Hang Seng Falls Despite Wall Street Rally Amid Xi-Biden Phone Call

By Bhavik Nair

July 28, 10:26 PM

Hong Kong’s benchmark Hang Seng Index was in the red on Friday, losing over 0.5% in opening trade, despite a continuing rally on Wall Street. Alibaba shares fell close to 4% following reports Chinese billionaire Jack Ma is planning to cede control of Ant Group.

AAPL

Advent, Stada Among Suitors For Viatris OTC ARM

Related Posts

Oncorus Announces Publication In Nature Communications Highlighting The Development Of Its Intravenously Administered Synthetic vRNA/LNP Platform For The Treatment Of Cancer

Albertsons Companies Issues Statement Regarding The Further Delay Of The Washington State Court’s Hearing On Its Special Dividend Payment

Amarin Corporation Shareholders Have Voted To Elect All 7 Of Sarissa’s Nominees, Remove Per Wold-Olsen As Chairman Of Board Effective Immediately

Alibaba Slumps 4% After Reports Of Jack Ma’s Plan For Ant: Hang Seng Falls Despite Wall Street Rally Amid Xi-Biden Phone Call